Literature DB >> 1490140

Perimetric follow-up in glaucoma with a reduced set of test points.

J Weber1, M Diestelhorst.   

Abstract

The global mean defect (GM) is probably the most useful visual field index for glaucoma follow-up. We compared 50 regional subsets of test locations to estimate the GM. Using the data on 424 automated fields of 257 patients with either primary open-angle glaucoma or ocular hypertension, we calculated the partial sample error of the regional mean defect as compared with the GM. In many regions, the measured sample error was greater than expected for a representative sample of points. Some sample errors were up to 5 times larger (regions "upper hemifield" and "lower hemifield"). Only a few subsets proved to be representative of the whole field, namely, regions "ring 3" (10 degrees-15 degrees), "ring 4" (15 degrees-20 degrees) and "ring 5" (20 degrees-25 degrees). The use of such programs for follow-up is very accurate for staging. Moreover, theoretical calculations reveal that trend analysis is even more significant if the reduction in examination time is combined with a proportional increase in examination frequency.

Entities:  

Mesh:

Year:  1992        PMID: 1490140

Source DB:  PubMed          Journal:  Ger J Ophthalmol        ISSN: 0941-2921


  3 in total

1.  How often do patients need visual field tests?

Authors:  A C Viswanathan; R A Hitchings; F W Fitzke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

Review 2.  Automated perimetry in glaucoma--room for improvement?

Authors:  C O'Brien; J M Wild
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

3.  Predicting progressive glaucomatous optic neuropathy using baseline standard automated perimetry data.

Authors:  Shaban Demirel; Brad Fortune; Juanjuan Fan; Richard A Levine; Rodrigo Torres; Hau Nguyen; Steven L Mansberger; Stuart K Gardiner; George A Cioffi; Chris A Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.